PRTA — Prothena Corporation plc · rev $1.0M

Prothena Corporation plc (PRTA) is a biotechnology company listed on US.

Latest reported PRTA revenue for 2026-06-30 was $1.0M. Net income was -$18.6M. Revenue was down 98.0% from 2026-03-31 to 2026-06-30. PRTA currently screens at market cap $460.2M.

Use this PRTA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PRTA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PRTA SEC filings page. Lician reads the product cache first so this HTML stays unique to Prothena Corporation plc even when a live quote feed is slow.

Prothena Corporation plc latest statements (FY2025)

Latest cached year on this hub. Full PRTA income, balance, and cash tables.

  • Revenue$9.7M
  • Net Income-$244.1M
  • Total Assets$326.8M
  • Total Debt$0
  • Free Cash Flow$0